Sam Hedgpeth, CPA

Sam Hedgpeth, CPA has a diverse work experience in the financial and accounting field. Sam most recently served as the Senior Director of Financial Planning Analysis at A2 Biotherapeutics, Inc. starting in June 2022. Prior to that, they held positions at Adverum Biotechnologies, where they served as the FP&A Sr. Director from January 2020 to June 2022 and as the FP&A Director from December 2020 to December 2021.

Before joining Adverum Biotechnologies, Sam worked at Rakuten Medical as the FPA Senior Manager from August 2019 to December 2020 and as the FPA Manager from October 2018 to July 2019. Sam also gained experience at Portola Pharmaceuticals where they served as the Accounting Manager from January 2018 to March 2018 and as the Sr. Accountant, R&D from March 2015 to December 2017.

Earlier in their career, Sam was employed at InterMune where they held the positions of Senior Revenue Analyst, FPA - Commercial Ops from July 2014 to February 2015 and Senior Accountant from December 2013 to July 2014. Sam began their professional journey at PwC, working as a Senior Associate from June 2012 to November 2013 and as an Experienced Associate from January 2010 to June 2012.

Sam Hedgpeth, CPA attended UC Santa Barbara from 2005 to 2009, where they obtained a Bachelor of Arts (B.A.) degree. Their degree focused on the fields of Business/Managerial Economics and History. Additional educational experiences or degrees beyond this information are unknown.